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EbrAB in Bacillus subtilis belongs to a novel small multidrug resistance (SMR) family of multidrug efflux pumps. EmrE in Escherichia coli, a
representative of SMR, functions as a homo-oligomer in the membrane. On the other hand, EbrAB requires a hetero-oligomeric configuration
consisting of two polypeptides, EbrA and EbrB. Although both polypeptides have a high sequence similarity, expression of either single
polypeptide does not confer the multidrug-resistance. We performed mutation studies on EbrA and B to determine why EbrAB requires the hetero-
oligomerization. Mutants of EbrA and B lacking both the hydrophilic loops and the C-terminus regions conferred the multidrug-resistance solely
by each protein. This suggests that the hydrophilic loops and the C-terminus regions constrain them to their respective conformations upon the
formation of the functional hetero-oligomer.
© 2006 Elsevier B.V. All rights reserved.Keywords: EbrAB; EmrE; Smr; Ion-coupled transporter; Multidrug resistance1. Introduction
The small multidrug resistance (SMR) family consists of
small membrane proteins that extrude various toxicants from
cells by utilizing the proton gradient across the membrane [1].
SMR proteins are widespread in bacteria and archaebacteria
including pathogenic organisms and have several unique
characteristics [2]: they are only 100–120 amino acids long,
forming four tentative transmembrane α-helices, and have very
high hydrophobicity, making them soluble in an organic
solvent [1,3]. Many aspects of SMR proteins have been
clarified so far through studies on EmrE, the SMR represen-
tative, in E. coli. It has been shown that EmrE functions in an
oligomeric state [4–8]. This is consistent with the results of
electron and X-ray crystallographic studies [9–12]. Although
structures proposed by these studies are different, both reveal
the dimer as a repetitive unit in the crystal, and of interest, the
dimer shares a unique feature that EmrEs form a homo-dimer
with an asymmetric structure.⁎ Corresponding author. Tel.: +81 11 706 7199; fax: +81 11 706 7321.
E-mail address: kikukawa@cast.hokudai.ac.jp (T. Kikukawa).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.04.004EbrAB and YkkCD in B. subtilis belong to a novel SMR
family [13,14]. These proteins are encoded from a gene pair
(ebrA and B or ykkC and D) in distinct operons, and expression
of a sole member cannot confer the multidrug-resistance. Both
members in the operon (EbrAB or YkkCD) are necessary for the
multidrug efflux pump. This implies that EbrA and B, or YkkC
and D, function as hetero-dimers. Here, a question arises: why
does EbrAB require the hetero-oligomerization although EmrE
does not? There must be factors that determine the respective
roles and/or conformations of EbrA and B (or YkkC and D). To
clarify these factors, we compared the amino acid sequences of
the monomers of SMR pairs (EbrA and B types) and other SMR
homologues (EmrE type) and then focused on the hydropho-
bicity differences in the loop and C-terminus regions between
these three types.
Three operons of B. subtilis and one operon of E. coli encode
the respective pairs of component proteins constituting the SMR
family [14]. In these SMR pairs, one member is commonly
shorter (105–109 residues), while the other is longer (109–121
residues) due to the hydrophilic C-terminus extension. More-
over, the shorter member has hydrophilic regions in tentative
loops, while the longer member and other SMR homologues do
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roles of their hydrophobicities in the efflux function by using a
mutation approach. The resulting EbrA and B mutants are
functional solely by the expression of each single member.2. Materials and methods
2.1. Construction of expression plasmids
At first, we constructed three plasmids for the respective and simultaneous
expressions of EbrA and B. The B. subtilis genes ebrA, and ebrB and the gene
pair ebrAB were amplified by polymerase chain reaction (PCR) from B. subtilis
ATCC 6051. The primers were designed based on the sequences in the GenBank
database (accession number, NC_000964). The ebrA sequence in the database
includes theNdeI site near the start codon, so the ebrA sense primer was designed
to substitute theNdeI site with a synonymous sequence. By PCR, additionalNdeI
and SalI sites were introduced at the ends of the target genes. The primers used
were as follows: for ebrA, 5′-TTATGAATTCATATGTTGATAGGATATA-
TATTCCTCACGATTGCCATTTGTTCGGAATCGATAGGAG-3′ (sense) and
5′-TCTGGTCGACTTACGGCCAATTAAGTAACAC-3′ (antisense); for ebrB,Fig. 1. Multiple alignments of amino acid sequences of SMR homologues. These hom
respective operons; middle and bottom, short and long components encoded in one op
the asymmetric dimer in the X-ray crystal structure of EmrE (PDB entry 2F2M) [12].
the asymmetric orientation of the monomer in the dimeric structure. The numbers ab
EbrB of B. subtilis, and acidic and basic amino acid residues are marked in black. Fo
marked by gray boxes. Strictly conserved residues are marked with an asterisk (*
respectively. Sequences were obtained from the National Center for Biotechnology I
NP_863640, Smr of S. aureus; NP_337671, EmrE of M. tuberculosis; NP_405870
subtilis; NP_391330, YvdR of B. subtilis; NP_416116, YdgE of E. coli; NP_389611
subtilis; NP_416117, YdgF of E. coli. Sequence for Hsmr of H. salinarum was ob
OE3652F. Alignment was performed using ClustalW at http://clustalw.genome.jp/.5′-TTATCATATGAGAGGATTGCTTTATTTG-3′ (sense) and 5′-TCTGG-
TCGACTCACTCACAGGCCGTCTG-3′ (antisense); and for ebrAB, the ebrA
sense and ebrB antisense primers. The PCR products were restricted, and the
resultant DNA fragments were ligated to the NdeI and SalI sites of pFLAG-CTC
(Sigma). The DNA sequences were determined using a standard procedure (377
DNAsequencer,AppliedBiosystems).Except for theprimer regions, theobtained
sequences were the same as those in the GenBank database. The plasmids
constructedfor therespectiveexpressionsofEbrAandBwereusedas templates for
the following mutations.
The mutations of EbrA on loop 1–2 or 3–4 were introduced using the
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) and sets of
two overlapping primers containing the desired mutations. These mutations
represent the residue replacement in the loop regions: for loop 1–2, KKWK at
position 29–32 was replaced with TQAW; for loop 3–4, KWFKED at position
78–83 was replaced with LLFGET. For mutation in both loops, the same
procedure for loop 3–4 mutation was repeated relative to the plasmid of EbrA
mutated in loop 1–2. The C-terminus mutants of EbrA, EbrB, and EbrA mutated
in both loops 1–2 and 3–4 were obtained by PCR and followed by insertion of
the PCR products into the pFLAG-CTC plasmid, where the antisense primers
for PCR contain the desired mutations for the C-terminus regions. These
mutations represent that for EbrB, the truncation after the histidine residue at
position 107, and that for EbrA and the EbrA mutant in the loop regions, theologues are classified into three groups: top, homologues encoded solely in the
eron as gene pairs. Solid and broken line arrows indicate the α-helical regions of
The differences in the regions indicated by solid and broken lines originate from
ove each group represent the amino acid numbers of EmrE of E. coli, EbrA, and
r the middle group, the loop regions having closely packed charged residues are
). Conserved and semiconserved substitutions are represented by (:) and (.),
nformation Protein database, accession numbers: NP_415075, EmrE of E. coli;
, QacE of Y. pestis; NP_389612, EbrA of B. subtilis; NP_389193, YkkD of B.
, EbrB of B. subtilis; NP_389192, YkkC of B. subtilis; NP_391329, YvdS of B.
tained from HaloLex (H. salinarum database http://www.halolex.mpg.de) code
Fig. 2. Hydrophobicity plots of SMR homologues. Panels of A, B, and C
correspond to three groups in Fig. 1, respectively. A: , EmrE (E. coli); \,
QacC (S. aureus); - - -, EmrE (M. tuberculosis); · · ·, QacE (Y. pestis); -·-·-,
Hsmr (H. salinarum); B: , EbrA (B. subtilis); \, YkkD (B. subtilis); - - -,
YvdR (B. subtilis); · · ·, YdgE (E. coli); C: , EbrB (B. subtilis); \, YkkC (B.
subtilis); - - -, YvdS (B. subtilis); · · ·, YdgF (E. coli). The top group has high
hydrophobicity over the entire proteins, while the middle and bottom groups
have hydrophilic regions in loops 1–2 and 3–4 for the middle group and in the
C-terminus regions for the bottom group. Hydrophobicities were calculated
using the Kyte and Doolittle scale [21] by the window size of 9. To calculate
hydrophobicities of the N- and C-terminus regions, we assumed that four
amino acid residues having a hydrophobicity index of 0 connect with the
protein terminuses.
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mutated in the loops was used as a PCR template for its C-terminus mutation.
The mutations introduced into the plasmids were confirmed by DNA sequencing
to ensure that no other mutations occurred.
2.2. Ethidium efflux assay in E. coli cells
Ethidium is a representative substrate of SMR proteins. We measured the
ethidium efflux activities of cells harboring various types of plasmids using the
method of Masaoka et al. [13] with a few modifications. The pFLAG-CTC
plasmid with no insert was used for a negative control. The expression host was
E. coli strain AS1, which lacks AcrA, a subunit of a major multidrug efflux
transporter. Cells were grown at 37 °C in LB broth [15] supplemented with
100 μg/ml of ampicillin. The precultures were prepared by growing the cells
until the optical density at 660 nm was between 0.5 and 0.7 and were then stored
at 4 °C. The next day, the main cultures, supplemented with 10 μM of IPTG,
were inoculated with 0.5% preculture. The IPTG concentration we used (10 μM)
led to strong efflux activity in the cell harboring the EbrAB plasmid without
significant hindering of the growth. After 6-h incubation, the optical density at
660 nm was 0.4 to 0.9. The cells were then harvested by centrifugation.
In the following procedure, the minimummedium derived fromM9 [15] was
used as a basal medium, which lacked glucose and was supplemented with
0.1 mM of CaCl2, 0.2 mM ofMgSO4 and 40 μg/ml of chloramphenicol. The cell
pellets were washed twice with the basal medium supplemented with 40 μM ofcarbonylcyanide m-chlorophenylhydrazone (medium A). They were then
resuspended in the medium A supplemented with 5 μM of ethidium bromide
(medium B) at the optical density of 0.5 at 660 nm. The cell suspensions were
shaken at 37 °C to deplete the energy of the cells and to load them with ethidium.
After 1 h, they were harvested by centrifugation and washed twice with the basal
medium supplemented with 5 μM of ethidium bromide (medium C). Finally, the
cells were resuspended in the medium C at the optical density of 0.25 at 660 nm.
The time-dependent decrease in the ethidium remaining in the cells was
measured with a Hitachi F-2000 fluorometer at 37 °C. After 5-min
preincubation, glucose was added (final concentration of 0.5% W/V) to the
suspension to energize the cells for the ethidium efflux. The excitation and
emission wavelengths were 545 and 610 nm, respectively.
2.3. Drug susceptibility test
Drug assay plates were prepared with LB agar containing 50 μg/ml of
ampicillin, 10 μM IPTG, and various concentrations of drugs. E. coli AS1 cells
harboring various plasmids were grown in the above LB medium lacking drugs
at 37 °C until the optical density at 660 nm was between 0.2 and 0.4. These
cultures were diluted in the same medium at the optical density of 0.005 at
660 nm, and 5 μl of the samples were plated on the drug assay plates. These
plates were incubated at 37 °C for 11 h, and thereafter the growth was evaluated.
2.4. SDS-PAGE analysis of E. coli membrane fractions
Cells grown using the same procedure for ethidium efflux assay were
harvested and washed twice with a buffer solution containing 400 mM of NaCl
and 50 mM of sodium phosphate (pH 7.0). The cells were resuspended in the
same buffer and disrupted by sonication. The membrane fraction was collected
by ultracentrifugation at 106,000×g for 1.5 h at 4 °C and analyzed by tricine–
SDS-PAGEwith 4% acrylamide stacking and 16.5% acrylamide separating gels.3. Results and discussion
Four pairs of SMR homologues encoded in distinct operons
are reported in B. subtilis (EbrAB, YkkCD, and YvdRS) and E.
coli (YdgEF) [14]. Because the pair consists of two compo-
nents, we call the short and long members of these SMR pairs
EbrA and EbrB homologues, respectively. In addition, the SMR
proteins solely encoded in the respective operon are called
EmrE homologues.
Fig. 1 shows the amino acid sequence alignments of these
homologues. The arrows indicate the tentative α-helical
regions from the X-ray crystal structure of EmrE [12]. The
acidic and basic amino acid residues are marked in black. Five
sequences in the top group are those of EmrE and its
homologues from human pathogens and archaeal bacteria.
The middle and bottom groups are the EbrA and EbrB
homologues, respectively. The most distinct difference among
these groups is seen in the C-terminus region. The EbrB
homologues have many charged residues at their prolonged C-
terminus, while the EmrE homologues have only one or two
charged residues in this region. The EbrA homologues
terminate in the middle of the last α-helical domain of EmrE,
so they lack such a hydrophilic C-terminal region. Except for
this region, the charged residues are similarly distributed in the
EmrE and EbrB homologues. The loop regions of the EbrA
homologues differ from those of the other homologues. In the
regions of loops 1–2 and 3–4, which are loops connecting
helices 1 and 2 and helices 3 and 4, the EbrA homologues have
closely packed charged residues.
Fig. 3. Time-dependent changes in intracellular ethidium concentrations. E. coli
strain AS1 cells harboring various expression plasmids were energy-starved and
loaded with ethidium. Ethidium remaining in the cells was monitored
continuously by measuring the fluorescence of ethidium. At time 0, glucose
(final concentration of 0.5% W/V) was added to the suspension to energize the
cells. Large downward deflections at time 0 are artifacts due to the glucose
addition. Expression plasmids harbored in particular cells are denoted in the
figure, where “None” means pFLAG-CTC having no insert, and EbrB(C)
represents the EbrB mutant lacking the region from Ala108 to its C-terminus. It
is noteworthy that EbrB(C) confers high efflux activity on the cells.
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terminus regions of these three groups, we created their
hydrophobicity plots. As shown in Fig. 2A, the EmrE
homologues have high hydrophobicity over the entire protein,
and the four transmembrane regions are, to some extent, clearly
indicated. The EbrB homologues (Fig. 2C) have similar
hydrophobicity profiles, but there are distinct differences from
the EmrE homologues in the C-terminus regions. The EbrB
homologues have a prolonged hydrophilic C-terminus, while
the EbrA homologues (Fig. 2B) lack the hydrophilic C-terminus
and have two hydrophilic regions in loops 1–2 and 3–4.Fig. 4. Mutated regions and hydrophobicity plots of EbrA mutants. (A) Comparison o
are marked with boxes. The sequences of EbrAwithin the boxes were replaced by th
EbrB(C) ( ), and EbrAmutant (\) assuming identical sequences in its three regions
regions, the hydrophobicity of EbrA closely resembles that of EbrB(C). HydrophobMutation studies on EmrE of E. coli have identified
essential amino acid residues: the representatives are Ala 10,
Glu 14, Phe 44, Tyr 60, and Trp 63 [6,16–20]. These residues
are essential for substrate binding, coupling between proton
and substrate flux, and stable expression of the protein itself.
Most of these residues are conserved in the three groups
shown in Fig. 1. Although an exception is seen in Tyr of
YdgF corresponding to Phe 44 of EmrE, the other EbrB
homologues fully conserve the Phe residue. Another excep-
tion is seen in Phe of YkkC and YvdS corresponding to Trp
63 of EmrE. However, two other EbrB homologues still
conserve the Trp residues. These facts contradict the idea that
EbrA and B homologues complementarily provide amino acid
residues indispensable for the multidrug efflux function. Thus,
the reason that the efflux function requires the complex
formation of EbrA and B homologues may originate from the
asymmetrical structure in the hetero-dimer. Upon the
formation of the functional complex, in other words, the
respective structure of EbrA and B homologues may be
complementary. The differences in hydrophobicities of the
loops and the C-terminus regions between the EbrA and B
homologues may determine their respective structures. Based
on this idea, we performed the following mutation study of
EbrA and B.
The distinct difference in hydrophobicity between the
EmrE and EbrB homologues lies in the prolonged hydrophilic
C-terminus regions of the EbrB homologues. Deletion of
these regions may make EbrB homologues solely functional.
Thus, we constructed the C-terminus-truncated EbrB and
examined its efflux activity for ethidium, a representative
substrate for SMR proteins. Four expression vectors were
constructed for the simultaneous expression of EbrA and B
and the sole expression of EbrA or EbrB or the EbrB
mutant lacking the region from Ala at position 108 to the
C-terminus.f amino acid sequences between EbrA and EbrB(C). Target regions for mutations
e corresponding sequences of EbrB(C). B: Hydrophobicity plots of EbrA (- - -),
, loops 1–2 and 3–4 and the C-terminus, as EbrB(C). Due to mutations in all three
icities were calculated by the same method for Fig. 2.
Fig. 5. Time-dependent changes in intracellular ethidium concentrations. E. coli
cells harboring expression plasmids of EbrA mutants are used. Measurements
were performed the same as in Fig. 3. In the respective EbrA mutants, the
regions identical with those of EbrB(C) are the C-terminus for EbrA(C), loop
1–2 for EbrA(L12), loop 3–4 for EbrA(L34), loops 1–2 and 3–4 for EbrA
(L12, 34), and loops 1–2 and 3–4 and the C-terminus for EbrA(L12,34,C).
Efflux activities of the cells were not increased significantly by mutations in
single regions, i.e., the C-terminus, loop 1–2 or loop 3–4. However, it is
noteworthy that EbrA becomes able to confer high efflux activities on the cells
by the mutations in the two loops or all three regions (EbrA(L12,34) and EbrA
(L12,34,C)).
Table 1
MICs for E. coli AS1 cells harboring various expression plasmids
Plasmid for MIC (μM)
EtBr a TPPCl b Acriflavine
None c 10 10 5
EbrA 10 10 5
EbrB 10 20 5
EbrAB 200 500 100
EbrB(C) d 50 200 10
EbrA(L12,34,C) e 50 100 10
a Ethidium bromide.
b Tetraphenylphosphonium chloride.
c pFLAG-CTC plasmid having no insert.
d EbrB mutant lacking the region from Ala108 to its C-terminus.
e EbrA mutant having sequences on loops 1–2 and 3–4 and the C-terminus
regions identical with those of EbrB(C).
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in E. coli cells harboring these expression vectors. The decrease
in the fluorescence intensity corresponds to the ethidium efflux
from the cells. The cells harboring the EbrA plasmid did not
show efflux activity. These harboring the EbrB plasmid showed
a slight activity, but it was very small compared with that of
cells expressing the complete pair of EbrA and B (EbrAB). It is
noteworthy that the cells expressing the C-terminus truncated
EbrB (EbrB(C)) shows high efflux activity. The mutation
supplied a sole protein with the efflux activity.
We also constructed five EbrA mutants. The target regions
for the mutations are shown in Fig. 4A. We constructed EbrA
mutants having loop and C-terminus regions identical withFig. 6. Ethidium efflux rate by cells harboring various expression plasmids.
Initial slopes of efflux curves shown in Figs. 3 and 5 were taken as indexes for
efflux activities of the cells, and relative efflux rates are plotted. Each bar
represents the mean±S.D. for between three and six measurements. With only
the C-terminus truncation, EbrB was able to confer high efflux activity on the
cells. For EbrA, on the other hand, mutations in both loops 1–2 and 3–4
conferred high efflux activity. Improvement in activity came from additional
mutation in the C-terminus region.those of EbrB(C). Fig. 4B shows the hydrophobicities for EbrA,
EbrB(C), and the EbrA mutant in three regions of loops 1–2 and
3–4 and the C-terminus. With mutation in all three regions, the
hydrophobicity is close to that of EbrB(C) over the entire
protein.
The ethidium efflux activities of the cells harboring EbrA
mutant plasmids are shown in Fig. 5. The mutations in single
regions, i.e., the C-terminus (EbrA(C)), loop 3–4 (EbrA(L34)),
and loop 1–2 (EbrA(L12)), did not confer strong efflux activity
on the cells. However, simultaneous mutations in two loops or
all three regions (EbrA(L12,34) and EbrA(L12,34,C)) remark-
ably increased the efflux activity of the cells.
In Fig. 6, the relative efflux activities of cells harboring
various plasmids are shown that were deduced from the initial
slopes of the curves in Figs. 3 and 5. For EbrB, a single mutation
of the C-terminus truncation dramatically increases the efflux
activity. For EbrA, mutations at a single site were not adequate.
Mutations in loops 1–2 and 3–4 were necessary to confer high
efflux activity on the cells. Additional mutation at the C-
terminus further improved the activity.
We also tested the abilities for cellular resistance to toxic
compounds by the cells harboring various plasmids. Table 1
shows the MICs of three representative drugs. Mutant cells of
EbrB(C) and EbrA(L12,34,C) led to clear increases in the MICs
compared with the control cell (“None”) and those expressing
EbrA and EbrB alone. However, the abilities of these mutants
did not attain the level expected from the ethidium efflux assay.Fig. 7. SDS-PAGE analysis of EbrAB and the mutants. Protein bands were
visualized by silver staining. Bands were detected for EbrAB, EbrB(C), EbrA
(L12,34), EbrA(L12,34,C). Their molecular weights calculated from amino acid
sequences are shown at the bottom. The bands similar to the EbrA band, the
lower band of “EbrAB” lane, appear in all samples including “None”. These
bands, which do not originate in the expression plasmids, seem to have a slightly
lower mobility than the EbrA band.
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EbrB(C) and EbrA(L12,34,C) were 0.67 and 0.94, respectively.
On the other hand, the MICs for ethidium were 200 μM for
EbrAB and 50 μM for both EbrB(C) and EbrA(L12,34,C).
Thus, the mutations enable the cells to extrude toxic drugs by
expression of a single component of EbrA or EbrB, but these
mutants may still be inferior to the native EbrAB especially in
the ability to confer drug resistance.
Jack et al. reported that YkkCD, another EbrAB-type SMR
of B. subtilis, confers resistance to a broader range of drugs than
the homo-oligomeric SMR [14]. Thus, the hetero-oligomeriza-
tion may bring about a certain advantage for the drug resistance
phenotype. The elucidations of the functional and mechanical
differences between homo- and hetero-oligomeric SMRs should
be an attractive subject for a future study.
In the present work, we utilized the efflux rate of
ethidium from the cells or MIC as the indicator for the
protein activity of substrate efflux function. However, these
parameters also depend on the amount of protein expressed
in the cell. The CBB staining of the SDS-PAGE gels of the
membrane fractions did not clarify the bands corresponding
to the target proteins. However, we found that those bands
could be enhanced by silver staining. Fig. 7 shows images of
the silver-stained SDS-PAGE gel. Two bands, one
corresponding to EbrA and one to EbrB, were observed
for a sample that originated from cells harboring the EbrAB
plasmid. Bands for EbrB(C) and EbrA(L12,34,C) were also
observed for samples from their corresponding cells.
Moreover, a weak band of EbrA(L12,34) was also observed.
For other samples, however, we could not detect distinct
bands. Thus, the expressions of EbrAB and those mutants
were detected only in the cells having strong activities for
the ethidium efflux. Why does the simultaneous expression
of EbrA and B result in the stable expression of both
proteins while the expressions of the single components do
not? The formation of the EbrAB complex is considered to
be indispensable for their stable expression. The formation of
this complex appears to be essential not only for their
function but also for assuming a stable structure within the
membrane. Mutations of EbrA or EbrB that confer the efflux
activities by the single components may induce their stable
expressions, possibly due to the oligomerization of the
homo-component.
The mutations conferring the activities by only one
component were only the C-terminus truncation for EbrB and
the modifications of the hydrophobicities at two or three regions
for EbrA. These results suggest that native EbrA and B are fully
equipped with the amino acid residues essential for drug efflux
function. In other words, EbrA and B do not seem to provide
complementarily the essential residues for the formation of the
functional EbrAB. Their respective conformations may be
complementary for the functional EbrAB complex. As shown
by the crystal structures of EmrE [9–12], it assumes asymmetric
structures in the homo-dimer. Moreover, Pornillos et al. recently
reported that the two subunits in the dimer assume antiparallel
configurations. This asymmetric structure may originate from
the high hydrophobicities on the entire EmrE molecule. ForEbrA and B, on the other hand, the presence of their hydrophilic
regions may restrict them to their respective conformations.
Mutations that remove their hydrophilic regions probably
enable them to solely assume antiparallel configurations as
does EmrE.Acknowledgements
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